Stock losses escalated in the closing minutes of Monday's session. The S&P 500 and Nasdaq backed off of all-time highs on Monday as a selloff among biotech stocks weighed on markets. Wall Street was also jittery ahead of the Federal Reserve's monthly two-day meeting which kicks off Tuesday. Mylan (MYL) was the worst performer on the Nasdaq and sparked a biotech selloff after its board unanimously rejected a $40 billion offer from Teva Pharmaceuticals (TEVA). Tesla (TSLA) brought some bounce to the Nasdaq though, topping the index ahead of a scheduled presentation on Thursday. The company is expected to unveil new batteries for use in the home energy market.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.